World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
129
Citations
58171
World Ranking
246
National Ranking
162

Medicine

D-Index
129
Citations
58492
World Ranking
2611
National Ranking
1466

Stanley J. Szefler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stanley J. Szefler sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 757 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stanley J. Szefler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stanley J. Szefler sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 129 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stanley J. Szefler is affiliated with the University of Colorado Denver in the United States. Their research primarily focuses on medicine, with a significant portion of work dedicated to pulmonary and respiratory medicine. Other subfields of study include physiology, general health professions, pediatrics, perinatology and child health, and speech and hearing.

The scientist's main topics of research cover a broad spectrum within respiratory health and related disciplines. These topics include:

  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Inhalation and respiratory drug delivery
  • Chronic obstructive pulmonary disease (COPD) research
  • Pharmaceutical studies and practices
  • School health and nursing education
  • Allergic rhinitis and sensitization

Szefler has contributed to numerous publications, with frequent appearances in specialized journals. Notable publication venues include:

  • The Journal of Allergy and Clinical Immunology In Practice
  • Journal of Allergy and Clinical Immunology
  • Pediatric Pulmonology
  • European Respiratory Journal
  • Annals of Allergy Asthma & Immunology

Recent papers authored by or including the scientist highlight the focus on respiratory and pediatric asthma-related issues, especially in the context of the COVID-19 pandemic. Some of these papers are:

  • COVID-19 and the impact of social determinants of health (2020), The Lancet Respiratory Medicine
  • Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden (2020), The Journal of Allergy and Clinical Immunology In Practice
  • The Impact of Social Determinants of Health on Children with Asthma (2020), The Journal of Allergy and Clinical Immunology In Practice
  • Digital Health Technology in Asthma: A Comprehensive Scoping Review (2021), The Journal of Allergy and Clinical Immunology In Practice
  • Managing Asthma during Coronavirus Disease-2019: An Example for Other Chronic Conditions in Children and Adolescents (2020), The Journal of Pediatrics

Stanley J. Szefler collaborates frequently with a number of researchers in their field. Regular coauthors include Leonard B. Bacharier, David A. Stempel, William W. Busse, Wanda Phipatanakul, and Leanne Kaye.

Best Publications

  • Long-term effects of budesonide or nedocromil in children with asthma.

    Stanley Szefler;Scott Weiss;James Tonascia

  • An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

    Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet

  • Long-term inhaled corticosteroids in preschool children at high risk for asthma.

    Theresa W. Guilbert;Wayne J. Morgan;Robert S. Zeiger;Robert S. Zeiger;David T. Mauger

  • Proceedings of the ATS Workshop on Refractory Asthma Current Understanding, Recommendations, and Unanswered Questions

    Sally E. Wenzel;John V. Fahy;Charles Irvin;Stephen P. Peters

  • Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    William W. Busse;Wayne J. Morgan;Peter J. Gergen;Herman E. Mitchell

  • Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.

    Sally E. Wenzel;Stanley J. Szefler;Donald Y. M. Leung;Steven I. Sloan

  • A summary of the new GINA strategy: a roadmap to asthma control.

    Helen K. Reddel;Eric D. Bateman;Allan Becker;Louis-Philippe Boulet

  • International consensus on (ICON) pediatric asthma

    N. G. Papadopoulos;H. Arakawa;A. Custovic;J. Gern

  • The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma

    Elliot Israel;Jeffrey M. Drazen;Stephen B. Liggett;Homer A. Boushey

  • Significant variability in response to inhaled corticosteroids for persistent asthma

    Stanley J. Szefler;Richard J. Martin;Tonya Sharp King;Homer A. Boushey

  • COVID-19 and the impact of social determinants of health.

    Elissa M Abrams;Elissa M Abrams;Stanley J Szefler

  • Characterization of within-subject responses to fluticasone and montelukast in childhood asthma

    Stanley J. Szefler;Brenda R. Phillips;Fernando D. Martinez;Vernon M. Chinchilli

  • Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

    Elliot Israel;Vernon M. Chinchilli;Jean G. Ford;Homer A. Boushey

  • Tiotropium bromide step-up therapy for adults with uncontrolled asthma

    Stephen P. Peters;Susan J. Kunselman;Nikolina Icitovic;Wendy C. Moore

  • A new perspective on concepts of asthma severity and control

    D. R. Taylor;E. D. Bateman;L.-P. Boulet;H. A. Boushey

  • Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma

    M J McGeachie;K P Yates;X Zhou;F Guo

  • Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids.

    J. C. Kam;S. J. Szefler;W. Surs;E. R. Sher

  • Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β

    Donald Y.M. Leung;Qutayba Hamid;Alessandra Vottero;Stanley J. Szefler

  • Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial

    Stanley J Szefler;Herman Mitchell;Christine A Sorkness;Peter J Gergen

  • Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma

    Theresa W. Guilbert;Wayne J. Morgan;Robert S. Zeiger;Robert S. Zeiger;Leonard B. Bacharier

Frequent Co-Authors

Donald Y.M. Leung
Donald Y.M. Leung National Jewish Health
Robert S. Zeiger
Robert S. Zeiger Kaiser Permanente
William W. Busse
William W. Busse University of Wisconsin–Madison
Harold S. Nelson
Harold S. Nelson National Jewish Health
Vernon M. Chinchilli
Vernon M. Chinchilli Pennsylvania State University
Robert F. Lemanske
Robert F. Lemanske University of Wisconsin–Madison
Richard J. Martin
Richard J. Martin Case Western Reserve University
Elliot Israel
Elliot Israel Brigham and Women's Hospital
Robert C. Strunk
Robert C. Strunk Washington University in St. Louis
Homer A. Boushey
Homer A. Boushey University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often leads students to explore various healthcare-related career paths, including advanced nursing roles. For those interested in combining immunology knowledge with clinical practice, nurse practitioner programs offer flexible online options. Many students seek the easiest np program to balance coursework with professional and personal commitments.

Mental health is a critical area where immunology intersects with patient care. Online Psychiatric-Mental Health Nurse Practitioner programs are popular, especially those with strong support structures like online pmhnp programs with clinical placement, ensuring hands-on experience despite remote learning.

Cost considerations are also vital when selecting a program. Prospective students can find options among the cheapest psych np programs that maintain quality education and accreditation. This makes advanced training more accessible to diverse learners.

Finally, understanding financial outcomes is important. Graduates with advanced degrees like the Doctor of Nursing Practice can refer to resources detailing the doctorate in nursing salary, which varies by location and specialty, helping them make informed career decisions in the health sciences.

Best Scientists Citing Stanley J. Szefler

Trending Scientists

Recently Published Articles